Skip to content
Research Article Open access CC BY 3.0

Anti-Cancerous Effect of 4,4'-Dihydroxychalcone ((2E,2'E)-3,3'-(1,4-Phenylene) Bis (1-(4-hydroxyphenyl) Prop-2-en-1-one)) on T47D Breast Cancer Cell Line

Narges Mahmoodi, Tayebeh Besharati-Seidani, Nasrin Motamed, Nosrat O. Mahmoodi

Annual Research & Review in Biology · pp. 2045–2052 · Published 13 Mar 2014

10.9734/ARRB/2014/8484

Abstract

Aims: The majority of human breast tumors are estrogen receptor α (ERα) positive. However, not all of the ERα+ breast cancers respond to anti-estrogens drugs for those women who do respond, initial positive responses can be of short duration. Thus, more effective drugs are needed to enhance the efficacy of anti-estrogens drugs or to be used separately in a period of time. In view of potential cytotoxicity associated with silybin as polyhydroxy compounds a synthetic 4-hydroxychalcones (bis-phenol) was considered to explore its anti-carcinogenic effects in comparison to silybin on ERα+ breast cancer cell line. Methodology: We have studied the inhibitory effect of 4,4'-dihydroxychalcone on the T47D breast cancer cell line by MTT test and the IC50s were estimated using Pharm PCS. Results: The 4,4'-dihydroxychalcone showed significant dose- and time-dependent cell growth inhibitory effects on T47D breast cancer cells. The IC50 of 4,4'-dihydroxychalcone on T47D cells after 24 and 48 hours was 160.88+/-1 µM, 62.20+/-1 µM and for silybin was 373.42+/-1 µM,176.98+/-1 µM respectively. Conclusion: Our results strongly suggests that this premade synthetic 4,4'-dihydroxychalcone can promote anti carcinogenic actions on T47D cell line. All 4,4'-dihydroxychalcone doses had a much larger inhibitory effect on cell viability than silybin doses in T47D cells. The ratio of the IC50 of 4,4'-dihydroxychalcone to silybin after 24 and 48 hours was 1: 2.3 and 1: 2.8 respectively.

Dihydroxychalcone breast cancer silybin T47D MTT

References (27)

  1. 1 A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes [DOI]
  2. 2 Molecular Profiling of Breast Cancer Cell Lines Defines Relevant Tumor Models and Provides a Resource for Cancer Gene Discovery [DOI]
  3. 3 Breast Cancer: Prevention and Control [DOI]
  4. 4 Licochalcone-A, a novel flavonoid isolated from licorice root (Glycyrrhiza glabra), causes G2 and late-G1 arrests in androgen-independent PC-3 prostate cancer cells [DOI]
  5. 5 Flavokawain A, a Novel Chalcone from Kava Extract, Induces Apoptosis in Bladder Cancer Cells by Involvement of Bax Protein-Dependent and Mitochondria-Dependent Apoptotic Pathway and Suppresses Tumor Growth in Mice [DOI]
  6. 6 Cytotoxic Activities of Mannich Bases of Chalcones and Related Compounds [DOI]
  7. 7 Antidiabetic Activities of Chalcones Isolated from a Japanese Herb, Angelica keiskei [DOI]
  8. 8 Chalcone inhibits the proliferation of human breast cancer cell by blocking cell cycle progression and inducing apoptosis [DOI]
  9. 9 A simple and highly efficient method for the synthesis of chalcones by using borontrifluoride-etherate [DOI]
  10. 10 Xanthoangelol, a Major Chalcone Constituent of Angelica keiskei, Induces Apoptosis in Neuroblastoma and Leukemia Cells [DOI]
  11. 11 Bisphenol A at Low Nanomolar Doses Confers Chemoresistance in Estrogen Receptor-α–Positive and –Negative Breast Cancer Cells [DOI]
  12. 12 Apigenin inhibits antiestrogen-resistant breast cancer cell growth through estrogen receptor-α-dependent and estrogen receptor-α-independent mechanisms [DOI]
  13. 13 Antitumor and antimetastatic activities of Angelica keiskei roots, part 1: Isolation of an active substance, xanthoangelol [DOI]
  14. 14 Structure−Activity Relationships of Methoxychalcones as Inducers of Heme Oxygenase-1 [DOI]
  15. 15 Synthesis, Analgesic and Anti‐Inflammatory Activity of 4‐(2‐Phenoxyphenyl)semicarbazones [DOI]
  16. 16 Photochromic behavior of several new synthesized bis‐1,3‐diazabicyclo[3.1.0]hex‐3‐enes [DOI]
  17. 17 Synthesis and photochromism of 1,3-diazabicyclo[3.1.0]hex-3-ene phenol rings [DOI]
  18. 18 Synthesis of Thiophene Derivatives of 1,3-Diazabicyclo[3,1,0]hex-3-ene [DOI]
  19. 19 Synthesis and Photochromic Properties of New Heterocyclic Derivatives of 1,3‐Diazabicyclo[3.1.0]Hex‐3‐Ene [DOI]
  20. 20 Synthesis of 4′‐Hydroxy‐3′‐piperidinomethylchalcone Derivatives and Their Cytotoxicity Against PC‐3 Cell Lines [DOI]
  21. 21 Novel potentiometric membrane sensor based on 6-(4-nitrophenyl)-2-phenyl-4,4-dipropyl-3,5-diaza-bicyclo[3,1,0] hex-2-ene for detection of strontium (II) ions at trace levels [DOI]
  22. 22 NMR structural elucidation and photochromic behavior of new 1,3-diazabicyclo[3.1.0]hex-3-ene derivatives [DOI]
  23. 23 Involvement of G1/S cyclins in estrogen-independent proliferation of estrogen receptor-positive breast cancer cells [DOI]
  24. 24 Photochromism of several synthesised 1,3-diazabicyclo[3,1,0]hex-3-ene derivatives [DOI]
  25. 25 Synthesis and cytotoxicity of 2,5-dihydroxychalcones and related compounds [DOI]
  26. 26 ChemInform Abstract: Synthesis and Photochromism of 1,3‐Diazabicyclo[3.1.0]hex‐3‐ene Phenol Rings. [DOI]
  27. 27 Synthesis of 4′‐Hydroxy‐3′‐piperidinomethylchalcone Derivatives and Their Cytotoxicity Against PC‐3 Cell Lines. [DOI]

Cited by 8

Advances in nanomicelles for sustained drug delivery

N. Amirmahani, N. Mahmoodi, Mohsen Mohammadi Galangash · 2017

A comparative study on the nanoparticles for improved drug delivery systems.

N. Mahmoodi, A. Ghavidast, N. Amirmahani · Journal of Photochemistry and Photobiology. B: Biology · 2016

Showing 5 of 8 known citations — external sources report more than can currently be individually listed.

Article metrics

Real usage data collected on this platform.

12

Page views

0

PDF downloads

0

Outbound clicks

8

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.